AI Article Synopsis

  • This pilot study indicates that using tirofiban during stenting of blocked saphenous vein grafts can lower the risk of minor heart tissue damage after the procedure.
  • The reduction in postprocedural myocardial necroses suggests that tirofiban may enhance the safety of stenting in these cases.
  • These findings pave the way for further research on the benefits of tirofiban in cardiovascular procedures.

Article Abstract

In this pilot study, we show that periprocedural administration of tirofiban during stenting of critically stenosed saphenous vein grafts, significantly reduces the occurrence of postprocedural minor myocardial necroses.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjcard.2005.04.044DOI Listing

Publication Analysis

Top Keywords

stenting critically
8
critically stenosed
8
saphenous vein
8
vein grafts
8
adjunctive treatment
4
treatment tirofiban
4
tirofiban troponin
4
troponin elevation
4
elevation stenting
4
stenosed aortocoronary
4

Similar Publications

Flow diversion is a transformative approach in neurointerventional surgery for intracranial aneurysms that relies heavily on effective antiplatelet therapy. The ideal approach, including the timing of treatment, the use of dual antiplatelet therapy (DAPT), and the number of flow-diverter devices to use, remains unknown. DAPT, which combines aspirin with a thienopyridine like clopidogrel, prasugrel, or ticagrelor, is the standard regimen, balancing thromboembolic protection and hemorrhagic risk.

View Article and Find Full Text PDF

: ST-segment elevation myocardial infarction (STEMI) remains a leading cause of mortality worldwide, primarily caused by acute thrombosis over atherosclerotic plaques. Simultaneous acute thrombosis in two coronary arteries is an exceptionally rare event. This report highlights a unique case of STEMI associated with cardiogenic shock due to dual coronary artery thrombosis and provides insights from a literature review on this rare condition.

View Article and Find Full Text PDF

An esophageal stent integrated with wireless battery-free movable photodynamic-therapy unit for targeted tumor treatment.

Mater Today Bio

February 2025

Department of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, 610041, China.

Article Synopsis
  • Esophageal cancer ranks as the eighth most common type of cancer globally and is the sixth leading cause of cancer-related deaths.
  • The study introduces an innovative esophageal stent that features a wireless, battery-free, movable photodynamic therapy (PDT) unit, designed for flexible and precise treatment of esophageal tumors.
  • The system integrates a light source for PDT to induce tumor cell death and an electrochemical pneumatic actuator that allows for real-time positioning of the light source, improving targeted therapy based on tumor progression.
View Article and Find Full Text PDF

Background: Coarctation of the aorta (CoA) in adults is rare. usually combined with dilatation of the ascending aorta. Further disease progression complicated by hematoma or dissection of the ascending aorta is even more complicated and dangerous.

View Article and Find Full Text PDF

Objective: Secondary sclerosing cholangitis (SSC) represents a disease with a poor prognosis increasingly diagnosed in clinical settings. Notably, SSC in critically ill patients (SSC-CIP) is the most frequent cause. Variables associated with worse prognosis remain unclear.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!